Skip to contentP
Pure Bioscience, Inc.
P
PUREPure Bioscience, Inc. Q1 2018 · 10-Q
Revenue$464.00K$464.00K−12.6% vs Q1 2017 Net Income-$2.34M-$2.34MN/M vs Q1 2017 EPS Diluted-$0.04-$0.04N/M vs Q1 2017 Operating Income-$1,927,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,040,000N/M Margins · derivedOperating margin-415.3%−114.5 pt vs Q1 2017
Net margin-504.1%−175.8 pt vs Q1 2017
ended Oct 31, 2017 · filed Dec 14, 2017 · 44 d after period end